These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 14006474)

  • 41. [Nil nocere: Hazards of treatment of lead poisoning with calcium versenate (mosatil and complexon)].
    WEINIG E; SCHWERD W
    Munch Med Wochenschr; 1958 Nov; 100(46):1788-9. PubMed ID: 13613297
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of lead encephalopathy with calcium disodium versenate; report of a case.
    BESSMAN SP; RIED H; RUBIN M
    Med Ann Dist Columbia; 1952 Jun; 21(6):312-5. PubMed ID: 14940105
    [No Abstract]   [Full Text] [Related]  

  • 43. [Problem of the effect of calcium varseniate (Ca-EDTA) on the kidney in the treatment of lead poisoning].
    MYSLAK Z; BUCZKOWSKI M
    Pol Arch Med Wewn; 1961; 31():853-6. PubMed ID: 13727285
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of calcium disodium versenate in the treatment of persons exposed to the effects of lead tetraethyl].
    GHERARDI M
    Folia Med (Napoli); 1956 Apr; 39(4):349-64. PubMed ID: 13344646
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical manifestations & therapy of lead poisoning with report of a fatal toxic nephrosis caused by Ca-EDTA (calcium versenate)].
    MOESCHLIN S
    Schweiz Med Wochenschr; 1957 Aug; 87(34):1091-6. PubMed ID: 13467181
    [No Abstract]   [Full Text] [Related]  

  • 46. Chelation in metal intoxication XVIII: Combined effects of thiamine and calcium disodium versenate on lead toxicity.
    Flora SJ; Singh S; Tandon SK
    Life Sci; 1986 Jan; 38(1):67-71. PubMed ID: 3079852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cytogenetic action of versenate (Na2-Ca-EDTA) in subjects with normal and increased blood lead levels (author's transl)].
    Sarto F
    Med Lav; 1980; 71(2):141-8. PubMed ID: 6780774
    [No Abstract]   [Full Text] [Related]  

  • 48. [Studies on the effect of calcium thiosulfate and dicalcium and disodium calcium versenate. I. Degree of ionization, acute and chronic toxicity].
    KLINGER W; KERSTEN L
    Acta Biol Med Ger; 1961; 6():447-52. PubMed ID: 14457025
    [No Abstract]   [Full Text] [Related]  

  • 49. [Urinary and fecal elimination of lead and behavior of porphyrin in feces and urine in experimental chronic lead poisoning treated with edathamil calcium-disodium].
    ZAMBRANO A; MANGIERI A; SILVESTRONI A
    Boll Soc Ital Biol Sper; 1955 Jun; 31(6):611. PubMed ID: 13269539
    [No Abstract]   [Full Text] [Related]  

  • 50. Calcium disodium edathamil therapy of lead intoxication. The significance of amino-aciduria.
    ANDREWS BF
    Arch Environ Health; 1961 Nov; 3():563-7. PubMed ID: 13861480
    [No Abstract]   [Full Text] [Related]  

  • 51. The value of mobilization of lead by ethylenediamine-tetra-acetate in the diagnosis of lead poisoning.
    TEISINGER J; SRBOVA J
    Br J Ind Med; 1959 Apr; 16(2):148-52. PubMed ID: 13651558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of chenta calcium disodium and ethylenediamine tetraacetic acid calcium disodium on experimental manganese, cadmium and mercury poisoning].
    EYBL V
    Cesk Fysiol; 1959 Apr; 8(3):183. PubMed ID: 13671518
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitative urinary coproporphyrin excretion and its relation to edathamil calcium disodium administration in children with acute lead intoxication.
    CHISOLM JJ; HARRISON HE
    J Clin Invest; 1956 Oct; 35(10):1131-8. PubMed ID: 13367209
    [No Abstract]   [Full Text] [Related]  

  • 54. Calcium disodium versenate in the therapy of lead encephalopathy.
    KARPINSKI FE; RIEDERS F; GIRSH LS
    J Pediatr; 1953 Jun; 42(6):687-99. PubMed ID: 13053370
    [No Abstract]   [Full Text] [Related]  

  • 55. [Aspects of the elimination of lead in saturnism during treatment with Versenate].
    PETTINATI L; GRIBAUDO C; COSCIA GC; SARACCO C
    Folia Med (Napoli); 1962 Feb; 45():89-104. PubMed ID: 14486040
    [No Abstract]   [Full Text] [Related]  

  • 56. [Problem of the therapy of chronic lead poisoning with ethylenediamine tetraacetic acid calcium disodium].
    SRBOVA J; TEISINGER J
    Arch Gewerbepathol Gewerbehyg; 1956; 14(6):579-93. PubMed ID: 13355405
    [No Abstract]   [Full Text] [Related]  

  • 57. Value of calcium disodium ethylenediaminetetraacetate and British anti-lewisite in therapy of lead poisoning.
    KEHOE RA
    Fed Proc; 1961 Sep; 20(3)Pt 2():196-9. PubMed ID: 14454838
    [No Abstract]   [Full Text] [Related]  

  • 58. THE PROPHYLACTIC USE OF DISODIUM-CALCIUM VERSENATE IN EXPERIMENTAL LEAD POISONING IN RABBITS. II. EFFECT ON CATALASE ACTIVITY OF ERYTHROCYTES.
    SROCZYNSKI J; JONDERKO G
    Arch Immunol Ther Exp (Warsz); 1964; 12():229-31. PubMed ID: 14166663
    [No Abstract]   [Full Text] [Related]  

  • 59. THE PROPHYLACTIC USE OF DISODIUM-CALCIUM VERSENATE IN EXPERIMENTAL LEAD POISONING IN RABBITS. I. EFFECT ON THE BLOOD LEVELS OF REDUCED GLUTATHIONE.
    SROCZYNSKI J; JONDERKO G
    Arch Immunol Ther Exp (Warsz); 1964; 12():225-8. PubMed ID: 14166662
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapy of lead poisoning by Hungarian-made calcium disodium ethylenediamine tetraacetate (Ca EDTA) marked as E. Gy. T. 1271].
    SOOS G; ROZSAHEGYI I; ERDODI Z
    Orv Hetil; 1959 Jul; 100():1081-4. PubMed ID: 13832840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.